Sabra Healthcare Reit Stock Price History
| SBRA Stock | USD 17.26 0.07 0.40% |
Below is the normalized historical share price chart for Sabra Healthcare REIT extending back to November 08, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sabra Healthcare stands at 17.26, as last reported on the 22nd of March, with the highest price reaching 17.36 and the lowest price hitting 17.11 during the day.
If you're considering investing in Sabra Stock, it is important to understand the factors that can impact its price. At this point, Sabra Healthcare is very steady. Sabra Healthcare REIT owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0464, which indicates the firm had a 0.0464 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Sabra Healthcare REIT, which you can use to evaluate the volatility of the company. Please validate Sabra Healthcare's Risk Adjusted Performance of 0.0236, semi deviation of 1.92, and Coefficient Of Variation of 4736.18 to confirm if the risk estimate we provide is consistent with the expected return of 0.0779%.
At present, Sabra Healthcare's Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 2.9 B, whereas Total Stockholder Equity is forecasted to decline to about 2.2 B. . At present, Sabra Healthcare's Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.53, whereas Price Earnings Ratio is forecasted to decline to 29.09. Sabra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 2002 | 200 Day MA 17.0536 | 50 Day MA 16.7712 | Beta 1.248 |
Sabra |
Sharpe Ratio = 0.0464
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | SBRA | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.68 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Sabra Healthcare is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sabra Healthcare by adding it to a well-diversified portfolio.
Price Book 1.5283 | Enterprise Value Ebitda 15.9318 | Price Sales 5.8679 | Shares Float 234.1 M | Dividend Share 1.2 |
Sabra Healthcare Stock Price History Chart
There are several ways to analyze Sabra Stock price data. The simplest method is using a basic Sabra candlestick price chart, which shows Sabra Healthcare price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 18, 2025 | 17.78 |
| Lowest Price | February 12, 2025 | 15.81 |
Sabra Healthcare March 22, 2025 Stock Price Synopsis
Various analyses of Sabra Healthcare's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sabra Stock. It can be used to describe the percentage change in the price of Sabra Healthcare from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sabra Stock.| Sabra Healthcare Price Daily Balance Of Power | (0.28) | |
| Sabra Healthcare Price Action Indicator | (0.01) | |
| Sabra Healthcare Price Rate Of Daily Change | 1.00 | |
| Sabra Healthcare Accumulation Distribution | 52,867 |
Sabra Healthcare March 22, 2025 Stock Price Analysis
Sabra Stock Price History Data
The price series of Sabra Healthcare for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 has a statistical range of 1.97 with a coefficient of variation of 2.38. The price distribution for the period has arithmetic mean of 16.67. The median price for the last 90 days is 16.61. The company completed stock split (1:3) on 16th of November 2010. Sabra Healthcare REIT had dividends distributed to its stock-holders on 2025-02-14.| Open | High | Low | Close | Volume | ||
| 03/21/2025 | 17.26 | 17.36 | 17.11 | 17.26 | 3,671,077 | |
| 03/20/2025 | 17.63 | 17.63 | 17.25 | 17.33 | 3,144,002 | |
| 03/19/2025 | 17.70 | 17.77 | 17.48 | 17.61 | 2,641,028 | |
| 03/18/2025 | 17.61 | 17.93 | 17.61 | 17.78 | 4,075,524 | |
| 03/17/2025 | 17.30 | 17.72 | 17.30 | 17.62 | 2,267,455 | |
| 03/14/2025 | 16.80 | 17.31 | 16.61 | 17.30 | 2,344,527 | |
| 03/13/2025 | 16.69 | 17.13 | 16.61 | 16.86 | 2,619,411 | |
| 03/12/2025 | 16.60 | 16.72 | 16.29 | 16.59 | 3,004,413 | |
| 03/11/2025 | 17.07 | 17.21 | 16.52 | 16.62 | 2,293,350 | |
| 03/10/2025 | 16.89 | 17.27 | 16.89 | 17.07 | 2,403,627 | |
| 03/07/2025 | 16.57 | 17.00 | 16.49 | 16.86 | 2,255,640 | |
| 03/06/2025 | 17.01 | 17.04 | 16.45 | 16.57 | 2,325,198 | |
| 03/05/2025 | 16.98 | 17.31 | 16.79 | 17.09 | 2,252,699 | |
| 03/04/2025 | 16.73 | 17.08 | 16.64 | 17.03 | 3,440,193 | |
| 03/03/2025 | 16.51 | 16.88 | 16.51 | 16.81 | 1,885,901 | |
| 02/28/2025 | 16.48 | 16.70 | 16.46 | 16.61 | 2,969,923 | |
| 02/27/2025 | 16.38 | 16.53 | 16.26 | 16.45 | 1,223,829 | |
| 02/26/2025 | 16.46 | 16.59 | 16.36 | 16.39 | 2,290,391 | |
| 02/25/2025 | 15.91 | 16.51 | 15.86 | 16.42 | 2,300,226 | |
| 02/24/2025 | 15.89 | 16.14 | 15.81 | 15.88 | 2,244,911 | |
| 02/21/2025 | 16.51 | 16.64 | 15.60 | 15.89 | 2,553,601 | |
| 02/20/2025 | 16.42 | 16.64 | 15.87 | 16.39 | 2,894,301 | |
| 02/19/2025 | 16.33 | 16.58 | 16.33 | 16.55 | 2,383,489 | |
| 02/18/2025 | 16.52 | 16.81 | 16.45 | 16.46 | 2,718,989 | |
| 02/14/2025 | 16.43 | 16.62 | 16.28 | 16.52 | 2,832,746 | |
| 02/13/2025 | 15.85 | 16.42 | 15.82 | 16.38 | 3,356,290 | |
| 02/12/2025 | 15.74 | 15.93 | 15.58 | 15.81 | 3,127,498 | |
| 02/11/2025 | 16.21 | 16.23 | 15.86 | 15.95 | 3,180,393 | |
| 02/10/2025 | 16.40 | 16.41 | 16.03 | 16.33 | 2,754,321 | |
| 02/07/2025 | 16.42 | 16.57 | 16.15 | 16.39 | 4,093,844 | |
| 02/06/2025 | 16.68 | 16.77 | 16.37 | 16.49 | 2,130,319 | |
| 02/05/2025 | 16.60 | 16.71 | 16.49 | 16.59 | 1,236,486 | |
| 02/04/2025 | 16.64 | 16.71 | 16.31 | 16.42 | 1,941,878 | |
| 02/03/2025 | 16.22 | 16.74 | 16.16 | 16.61 | 1,812,675 | |
| 01/31/2025 | 16.40 | 16.63 | 16.35 | 16.41 | 1,787,780 | |
| 01/30/2025 | 16.44 | 16.57 | 16.20 | 16.46 | 1,790,493 | |
| 01/29/2025 | 16.73 | 16.82 | 16.05 | 16.28 | 2,357,219 | |
| 01/28/2025 | 17.05 | 17.18 | 16.64 | 16.69 | 1,580,233 | |
| 01/27/2025 | 16.70 | 17.17 | 16.59 | 17.13 | 1,676,233 | |
| 01/24/2025 | 16.45 | 16.63 | 16.37 | 16.62 | 975,590 | |
| 01/23/2025 | 16.33 | 16.51 | 16.21 | 16.45 | 1,054,693 | |
| 01/22/2025 | 16.68 | 16.70 | 16.28 | 16.30 | 1,204,468 | |
| 01/21/2025 | 16.69 | 16.95 | 16.69 | 16.74 | 1,457,689 | |
| 01/17/2025 | 16.96 | 16.96 | 16.52 | 16.64 | 1,729,884 | |
| 01/16/2025 | 16.71 | 16.87 | 16.66 | 16.87 | 1,058,665 | |
| 01/15/2025 | 16.86 | 16.90 | 16.65 | 16.69 | 1,292,678 | |
| 01/14/2025 | 16.28 | 16.58 | 16.23 | 16.50 | 1,903,033 | |
| 01/13/2025 | 16.12 | 16.33 | 16.06 | 16.31 | 2,583,471 | |
| 01/10/2025 | 16.57 | 16.70 | 16.15 | 16.29 | 2,069,744 | |
| 01/08/2025 | 16.42 | 16.96 | 16.34 | 16.87 | 2,442,945 | |
| 01/07/2025 | 16.45 | 16.72 | 16.39 | 16.50 | 1,873,293 | |
| 01/06/2025 | 16.83 | 16.85 | 16.29 | 16.33 | 1,992,637 | |
| 01/03/2025 | 16.75 | 17.03 | 16.71 | 16.95 | 1,208,884 | |
| 01/02/2025 | 16.98 | 17.02 | 16.61 | 16.74 | 1,308,927 | |
| 12/31/2024 | 16.88 | 17.05 | 16.81 | 17.01 | 2,086,890 | |
| 12/30/2024 | 16.67 | 16.77 | 16.47 | 16.73 | 1,272,662 | |
| 12/27/2024 | 16.67 | 16.78 | 16.56 | 16.71 | 2,318,876 | |
| 12/26/2024 | 16.70 | 16.87 | 16.63 | 16.79 | 717,314 | |
| 12/24/2024 | 16.59 | 16.79 | 16.51 | 16.77 | 499,627 | |
| 12/23/2024 | 16.63 | 16.71 | 16.35 | 16.61 | 1,288,253 | |
| 12/20/2024 | 16.37 | 16.79 | 16.23 | 16.66 | 5,428,307 |
About Sabra Healthcare Stock history
Sabra Healthcare investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sabra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sabra Healthcare REIT will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sabra Healthcare stock prices may prove useful in developing a viable investing in Sabra Healthcare
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 236 M | 139.7 M | |
| Net Loss | -69.8 M | -66.4 M |
Sabra Healthcare Quarterly Net Working Capital |
|
Sabra Healthcare Stock Technical Analysis
Sabra Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Sabra Healthcare Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sabra Healthcare's price direction in advance. Along with the technical and fundamental analysis of Sabra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sabra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0236 | |||
| Jensen Alpha | 0.0069 | |||
| Total Risk Alpha | 0.1664 | |||
| Sortino Ratio | 0.0503 | |||
| Treynor Ratio | (0.1) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sabra Stock analysis
When running Sabra Healthcare's price analysis, check to measure Sabra Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabra Healthcare is operating at the current time. Most of Sabra Healthcare's value examination focuses on studying past and present price action to predict the probability of Sabra Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabra Healthcare's price. Additionally, you may evaluate how the addition of Sabra Healthcare to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |